Allison Dering-Anderson, PharmD, RP, FAPhA

Allison Dering-Anderson, PharMD, RP

Clinical Associate Professor

College of Pharmacy
Department of Pharmacy Practice and Science
986145 Nebraska Medical Center
Omaha, NE  68198-6145
402-559-2890 (Fax)

Teaching Activities:
Dr. Dering-Anderson is the community pharmacist in the Department of Pharmacy Practice and Science.  She is the coordinator of Law and Ethics courses, the Over-the-Counter Products elective, the Point of Care Testing elective, and the Immunization course.  She is a preceptor for a 4th year elective in health policy.  Dr. Ally lectures in Pharmacy and Health Care, Pharmaceutical Care, and Pharmacotherapy, all with a focus on community pharmacy. 

Research Activities and Interests:
Dr. Ally’s research and scholarship focuses on advancing the services provided by pharmacists in community pharmacies.  She is one of the developers of the national Point of Care Testing Certificate program and is a developer of the California Pharmacists Association’s Advanced Pharmacist training program.  She works with pharmacists and other health care providers to create collaborative practice agreements intended to improve patient care.  Dr. Ally is the College’s presenter on the policy issues surrounding the medical use of cannabis and cannabinoids.  She serves as the College’s representative on the campus legislative committee.  Ally is a member of the UNMC Interprofessional Academy of Educators and is active in work to improve teaching and learning across the campus.  Dr. Ally is the faculty sponsor for the College’s Phi Lambda Sigma chapter – the national pharmacists organization recognizing pharmacy leaders.

Recent Publications:

  1. Klepser D, Klepser M, Smith J, Dering-Anderson A, Nelson M, Pohren L; Utilization of Influenza and Streptococcal Pharyngitis Point-of-Care Testing in the Community Pharmacy Practice Setting.  Res in Social and Adm Pharm; 2 May 2017; doi:  10.1016/j.sapharm.2017.04.012
  2. Dering-Anderson, AM: El avance de los servicios de la farmacia comunitaria; el farmaceutico n.; 15 abril 2017; 40-45
  3. Klepser, DG; Klepser, ME; Dering-Anderson, AM; Morse, JA; Smith, JK; Klepser, SA; Community pharmacist-physician collaborative streptococcal pharyngitis management program; J Am Pharm Assoc 2016; 56(3): 323-329
  4. Klepser, ME; Klepser, DG; Dering-Anderson, AM; Morse, JA; Smith, JK; Klepser, SA; Effectiveness of a Pharmacist-Physician Collaborative Program to Manage Influenza-like Illness; J Am Pharm Assoc 2016; 56: 14-21
  5. Dering-Anderson, AM; Doyle, M; How to Safely Prescribe Upper Respiratory Symptom Relief for Hypertensive Patients; Contemporary Clinic; December 2015; 26-27
  6. Dering-Anderson, AM; Doyle, M; Challenges in the development of pharmacist-based point-of-care tests; Drug Target Review; Volume 2, Issue 4, 2015; 46-48
  7. Klepser, DG; Corn, CE; Schmidt, M; Dering-Anderson, AM; Klepser, ME; Health Care Resource Utilization and Costs for Influenza-like Illness Among Midwestern Health Plan Members; Journal of Managed Care & Specialty Pharmacy; 21(7), 568-573
  8. Akinwale, TP; Adams, AJ; Dering-Anderson, AM; Klepser, ME; Pharmacy-based point-of-care testing for infectious diseases:  Considerations for the pharmacy curriculum; Currents in Pharmacy Teaching & Learning; Jan-Feb, 2015, volume 7, Issue 1, Pages 131-136
  9. Gubbins, PO; Klepser, ME; Dering-Anderson, AM; Bauer, KA; Darin, KM; Klepser, S; Matthias, KR; Scarsi, K; Point-of-Care testing for infectious diseases:  opportunities, barriers, and considerations in community pharmacy; J Am Pharm Assoc 2014; 54:163-171
  10. Dering-Anderson, AMD; Gubbins, PO; Klepser, DG; Klepser, ME; When the   Words Really Do Matter; Letter to the Editor; AJPE: Vol 78, Iss.2, Article 42; January 2014